Suffering from Bipolar Disorder or Depression?
Therapy not enough?
Treatment Available, Most Insurance Accepted.
Call Today 877-331-2545

October 15, 2004

Bad and Good News on Bipolar Disorder Treatments

A recent report published by Decision Resources, Inc., suggest that the number of people receiving treatment for bipolar disorder will grow significantly over the next decade ( from 55% to 65% growth in the United States by 2013; from 40% to 50% in Europe by 2013; and from 40% to 50% in Japan by 2013).

The report goes further, however, and forecasts that new generic drugs (that are generally much less expensive than brand name drugs) will result in significantly lower drug treatment costs.

According to the new Pharmacor study entitled "Bipolar Disorder," sales of anticonvulsants, antipsychotics, and antidepressants will begin a steady decline after 2008 as they lose patent protection.

"Although diagnosis rates for bipolar disorder are on the rise - - the drug market for the disorder will be hurt by generic erosion," said Anathea Waitekus, analyst at Decision Resources.

All of this is good news for consumers.

Source: DRI Pharmacor

Comments

Post a comment


Type the characters you see in the picture above.

Remember Me?